Brief: Xbrane Biopharma Q3 EBITDA Loss Sek 20.7 Mln

Xbrane Biopharma AB

24/10/2025 07:19

Oct 24 (Reuters) - Xbrane Biopharma AB XBRANE.ST:

XBRANE BIOPHARMA Q3 NET INCOME SEK -24 MILLION

XBRANE BIOPHARMA Q3 REVENUE SEK 10.1 MILLION

XBRANE BIOPHARMA Q3 EBITDA SEK -20.7 MILLION

XBRANE BIOPHARMA Q3 EPS SEK -0.02

Q3 REVENUE AMOUNTED TO SEK 10.1 M (16.2).

Q3 EBITDA AMOUNTED TO SEK −20.7 M (−20.4).

Source text: ID:nMFN1y2ZQs

Further company coverage: XBRANE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))